WHO counted 283 million people with alcohol use disorders
That 2016 estimate sits beside a word coined in 1852 that clinics now often avoid. Genes and environment share the risk roughly equally, and a first-degree relative with the disorder raises odds three- to fourfold—yet most relatives still never develop it.
Alcoholism means continuing to drink despite problems one cannot manage; some definitions also require dependence and withdrawal. Clinicians increasingly prefer alcohol use disorder or alcohol dependence because alcoholism and alcoholic feel stigmatizing. The World Health Organization estimated 283 million people with alcohol use disorders worldwide in 2016. Heavy use can injure every organ system, especially brain, heart, liver, pancreas, and immunity, and can cut life expectancy by about ten years. Direct alcoholism deaths numbered about 139,000 worldwide in 2013, while broader alcohol-attributable deaths were estimated near 3.3 million in 2012—and similar global figures still hover around 3.3 million deaths a year, about 5.9 percent of all deaths.
Cause is split: environment and genetics each get roughly half the blame. Having a parent or sibling with an alcohol use disorder multiplies risk three to four times, though only a minority of those relatives develop the disorder. Stress, anxiety, cheap supply, and easy access raise odds further. Binge drinking—often defined as five or more drinks for men or four for women on one occasion—is the most common pattern. Tolerance and physical dependence make stopping hard; blackouts, failed quit promises, and life falling apart around drink are classic warning signs. In 2023 WHO stated that no level of drinking is safe, including cancer risk at low or moderate intake.
Women often accrue long-term organ damage faster than men and show higher alcoholism mortality, including elevated breast-cancer risk. About 10 percent of dementia cases are linked to alcohol, making it the second leading cause of dementia in that framing. Depression frequently co-travels, sometimes remitting with abstinence and sometimes not. Withdrawal can be medically dangerous, so cessation is often supervised; benzodiazepines ease withdrawal, while acamprosate, naltrexone, or disulfiram target craving and reward. Therapy and mutual-aid groups such as Alcoholics Anonymous remain common supports, and a 2020 review found clinical programs that boost AA participation can help.
Source: Alcoholism
